Frequently Asked Questions
The market is segmented based on , By Product (Service, NGS Commercial Software and Others), Workflow (Primary Data Analysis, Secondary Data Analysis and Tertiary Data Analysis), Mode (In-house Data Analysis and Outsourced Data Analysis), Read Length (Long Read Sequencing, Short Read Sequencing, Very long Read Sequencing), End-Use (Academic Research, Clinical Research, Hospitals and Clinics, Pharma and Biotech Entities and Others) – Industry Trends and Forecast to 2030.
.
The Global Next Generation Sequencing Data Analysis Market size was valued at USD 778.46 USD Million in 2022.
The Global Next Generation Sequencing Data Analysis Market is projected to grow at a CAGR of 16.7% during the forecast period of 2023 to 2030.
The major players operating in the market include Thermo Fisher ScientificInc. , QIAGEN , IlluminaInc. , F. Hoffmann-La Roche Ltd. AGilent TechnologiesInc. , Bio-Rad LaboratoriesInc. , Pierian , Precigen , Partek Incorporated , Eurofins Scientific , PacBio , DNASTAR Congenica Ltd. , Fabric GenomicsInc. , DNAnexus Inc. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
